NHIA Launches National Home Infusion Foundation (NHIF) to Promote Long-term Leadership, Research, and Education Within Industry

During the Opening General Session of the 2014 NHIA Annual Conference & Exposition (held in Orlando, Florida), NHIA's President & CEO, Russ Bodoff, announced the formal launch of the National Home Infusion Foundation (NHIF), a 501(c)(3) non-profit foundation (thus allowing charitable contributions made to the Foundation to be tax deductible to the extent permitted by law) that will support the advancement of the industry by building the capabilities of infusion professionals and stakeholders through leadership, education, and research.

"While NHIA is focused on advancing the industry and ultimately supporting the growth of home and specialty infusion businesses, the Foundation is geared towards the infusion professionals involved in those businesses," said Bodoff.

During a panel discussion facilitated by NHIA Senior Vice President & COO Steve Jurich, conference attendees gained additional insight on the Foundation and its role in advancing the home and specialty infusion therapy industry. Panelists included Foundation Board Chair Chris Maksym, Pharm.D., Director of Pharmacy and Home Care Operations for the University of Michigan—HomeMed, and NHIF Board members Tony Powers, Pharm.D., CEO of Medical Alternatives and Lynn Giglione, R.N., B.S.N., President & CEO of Chartwell Pennsylvania (Note: regrettably, Lynn Giglione passed away on April 30, 2014. See tribute article on pages 6 - 7 of INFUSION magazine, the official publication of the National Home Infusion Association). Also serving on the Foundation's Board is NHIA President & CEO, Russ Bodoff.

To kick-off the discussion, Jurich shared that the formal NHIF mission "is to advance home and specialty infusion leadership, education and research, and to further elevate infusion practice to the highest level of patient care and value."

Giglione, who was the NHIA Board Chair at the time the strategic concept of the Foundation was originally conceived, added, "NHIF will look to preserve the future of the field and ensure continued enhancement of patient care and patient outcomes through its varied activities."

"The Foundation will aim to ensure that the delivery of high-quality infusion care continues to improve with future generations of practitioners," asserted Maksym.

"It will also focus on advancing the capabilities of leaders in the field, working with educators to enhance curriculums on infusion therapy, and identifying opportunities for field-specific research to advance patient care," affirmed Powers—who also called upon all industry stakeholders to get involved in supporting NHIF endeavors via contributing both ideas and funding to help get the Foundation off the ground.

"NHIF represents a new, exciting initiative that will specifically focus on investing in the future of the home and specialty infusion therapy industry," Jurich explained. "The ideas that propelled the establishment of this Foundation were forged from the desire to see our field flourish—and to acquire the support and resources our industry needs to fulfill its mission of continually improving patient care and patient outcomes."